기계환기 치료 없이 회복한 신종플루에 의한 급성호흡곤란 증후군 -증례 보고-
H1N1 Influenza/A Associated ARDS Recovered without Mechanical Ventilatory Support -A Case Report-
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
An eighteen year-old female visited the ER in our hospital with fever of 38.5℃ for 2 days. She also had cough, myalgia, and dyspnea. Chest PA and lung HRCT showed mild pulmonary edema at both hilar areas. However, she had severe hypoxia (PaO_2; 58 mmHg in room air). RT-PCR for H1N1 influenza/A of pharyngeal swab was positive. Tamiflu (150 mg/d) with broad-spectrum antibiotics was prescribed. Two days later, her dyspnea aggravated and chest PA showed diffuse bilateral infiltration. PaO_2 dropped to 70 mmHg (O_2 10 L/min by face mask with reservoir bag). She was transferred to the MICU and the Tamiflu dose was doubled (300 mg/day). Mechanical ventilator was set aside to prepare respiratory failure. Fortunately, her symptoms and oxygenation improved and she was discharged with full recovery. Although, most cases of ARDS require mechanical ventilatory support, early and adequate dose of Tamiflu may avoid it in the case of ARDS developed by H1N1 influenza/A.
Abstract
An eighteen year-old female visited the ER in our hospital with fever of 38.5℃ for 2 days. She also had cough, myalgia, and dyspnea. Chest PA and lung HRCT showed mild pulmonary edema at both hilar areas. However, she had severe hypoxia (PaO_2; 58 mmHg in room air). RT-PCR for H1N1 influenza/A of pharyngeal swab was positive. Tamiflu (150 mg/d) with broad-spectrum antibiotics was prescribed. Two days later, her dyspnea aggravated and chest PA showed diffuse bilateral infiltration. PaO_2 dropped to 70 mmHg (O_2 10 L/min by face mask with reservoir bag). She was transferred to the MICU and the Tamiflu dose was doubled (300 mg/day). Mechanical ventilator was set aside to prepare respiratory failure. Fortunately, her symptoms and oxygenation improved and she was discharged with full recovery. Although, most cases of ARDS require mechanical ventilatory support, early and adequate dose of Tamiflu may avoid it in the case of ARDS developed by H1N1 influenza/A.
참고문헌 (11)
- Reed C, "Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009", Emerg Infect Dis, 15, pp.2004~2007 (2009)
- Miller E, "Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study", Lancet, 375, pp.1100~1108 (2010)
- "Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States" (2010)[URL]
- Choi WI, "Clinical characteristics and outcomes of H1N1-associated pneumonia among adults in South Korea", Int J Tuberc Lung Dis, 15, pp.270~275 (2011)
- Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, "Emergence of a novel swine-origin influenza A (H1N1) virus in humans", N Engl J Med, 360, pp.2605~2615 (2009)
- Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, "Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection", N Engl J Med, 362, pp.1708~1719 (2010)
- "CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States" (2009)[URL]
- Butler D, "Portrait of a year-old pandemic", Nature, 464, pp.1112~1113 (2010)
- Louie JK, "California Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California", JAMA, 302, pp.1896~1902 (2009)
- Hewagama S, "2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia", Clin Infect Dis, 50, pp.686~690 (2010)
- Reddy D, "Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir", J Antimicrob Chemother, 65(2), pp.ii35~ii40 (2010)